ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Barcelona, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Barcelona, CT, ESP:

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight (SELENE 2)

The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to pl...

Not yet enrolling
Diabetes Mellitus, Type 2
Obesity or Overweight
Drug: AZD6234
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Barcelona, Spain and 217 other locations

also to as NMX8 system), in comparison with other commercially available AID systems (Automated insulin delivery) in adult patients with Type 1 diabetes...

Begins enrollment this month
Type 1 Diabetes (T1D)
Device: AID Therapy
Device: NMX8 System - Control Arm
Medtronic MiniMed, Inc.

Barcelona, Spain and 20 other locations

The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on:*...

Enrolling
Overweight With Diabetes
Obesity With Diabetes
Drug: Ribupatide
Drug: Placebo

Phase 3

Kailera

Barcelona, Catalonia, Spain and 166 other locations

in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: Orforglipron
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Barcelona, Spain and 70 other locations

study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...

Active, not recruiting
Diabetes, Type 2
Type 2 Diabetes
Drug: PF-08653944
Other: Placebo

Phase 3

Pfizer
Pfizer

Barcelona, Spain and 188 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Barcelona, Spain and 78 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 229 other locations

The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective a...

Enrolling
Diabetes Mellitus, Type 2
Drug: UBT251
Drug: Semaglutide Placebo

Phase 2

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 70 other locations

the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes...

Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

Phase 3

Lilly
Lilly

Barcelona, Spain and 157 other locations

This study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when comp...

Enrolling
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: NNC0662-0419

Phase 2

Novo Nordisk
Novo Nordisk

Barcelona, Spain and 62 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems